Staphylococcus aureus Newman cells carry a surface receptor for fibrinogen called clumping factor. The bacteria also express coagulase, an extracellular protein that binds to prothrombin to form a complex with thrombinlike activity which coverts fibrinogen to fibrin. We have confirmed a recent report (M. K. Boden and J.-I. Flock, Infect. Immun. 57:2358-2363) that coagulase can bind to fibrinogen as well as to prothrombin and also that a fraction of coagulase is firmly attached to the cell. A mutant with a deletion in the chromosomal coa gene was isolated by allelic replacement. Allelic replacement either was directly selected by electrotransformation of S. aureus R3N4220 with a nonreplicating suicide plasmid, pCOA18, carrying the Acoa::Tcr mutation or occurred after transduction of the integrated pCOA18 plasmid. The coa mutant was completely devoid of coagulase activity but interacted both with soluble fibrinogen and with solid-phase fibrinogen with the same avidity as the parental strain. This strongly suggests that the bound form of coagulase is not clumping factor and is not responsible for the adherence of S. aureus Newman to solid-phase fibrinogen. The fibrinogen binding determinant of coagulase was located in the C terminus of the protein, by analyzing truncated fusion proteins, in contrast to the prothrombin-binding region which was located in the N terminus.
Purification of fibrinogen. Fibrinogen used for Western affinity blotting was purified as follows. A 200-mg amount of human fibrinogen (Sigma) was dissolved in 50 ml of phosphate-buffered saline (PBS) and passed through a gelatinSepharose column to remove contaminating fibronectin. Gelatin-Sepharose was prepared by coupling 10 mg of gelatin (BDH, Poole, United Kingdom) to 100 ml of CNBr-activated Sepharose 4B (Pharmacia) by using the procedure described by the manufacturer. The eluate was then passed through a column of protein A coupled to Sepharose (Pharmacia) to remove contaminating immunoglobulins. The (37) .
Measurement of attachment of bacteria to solid-phase fibrinogen. We have recently modified a previously described staphylococcal adherence assay (40) (41) (42) to measure the ability of S. aureus to adhere to low levels of surfaceadsorbed fibrinogen. Two-sided coverslips (8 by 9 mm) made of polymethylmethacrylate (PMMA) were prepared as previously described (42) . They were incubated for 60 min at 37°C with low concentrations (ranging from 0.125 to 1 ,ug/ml) of purified fibrinogen and were then rinsed once in PBS. It was ascertained that the PMMA surfaces were coated in a dose-dependent manner with fibrinogen amounts ranging from 16 to 145 ng per coverslip (11 to 101 ng/cm2) when a 3H-labelled preparation of fibrinogen was used (35) . Fibrinogen-coated coverslips were then incubated with 4 x 106 CFU of [3H]thymidine-labelled S. aureus per ml for 60 min at 37°C, as previously described (42) . The adherence medium was PBS with 1 mM Ca2' and 0.5 mM Mg2+, supplemented with 5 mg of human serum albumin per ml which prevented nonspecific adherence of S. aureus (40) (41) (42) ). Coverslips were then rinsed, and the number of attached bacteria was estimated from radioactive counts (42) . PMMA covxerslips coated with albumin were used as controls (40) (41) (42) (Fig. 1). A deletion of DNA located between these sites was involved in the formation of the coagulase mutation Acoa::Emr ( Fig.  1) 
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A lacZ-coa in-frame fusion expressing only the C-terminal 177 residues of coagulase was constructed by cutting pN-COA2 with HindIII (in coa) and BamHI (in the polycloning site adjacent to the KpnI site used in constructing pNCOA2), treating it with Klenow polymerase, and ligating it into the HinclI site of pUCKanl9. Kar transformants that were white on X-Gal (5-bromo-4-chloro-3-indoly-,-D-galactopyranoside) were screened for derivatives with the expected insert. These were subsequently tested for expression of a fibrinogen-binding protein by Western blotting. The plasmid expressing the LacZ-Coa fusion protein in E. coli was called pNCOA8.
RESULTS
Transfer of the &oa::Emr mutation to S. aureus Newman. It has been suggested that a cell-bound form of coagulase in S. aureus Newman is clumping factor (4) . The objective of this research was to test this notion genetically with coagulase-deficient mutants of the clumping-factor-positive strain S. aureus Newman. We had previously isolated a Coamutant of S. aureus 8325-4 (28), a strain which expresses low levels of both coagulase and clumping factor ( Table 3 ). The Acoa::Emr mutation had previously been constructed in vitro by replacing DNA between the EcoRI and HindIII sites in the coa gene of 8325-4 with a fragment expressing erythromycin resistance (28) (Fig. 1) . The mutation was introduced into strain 8325-4 by allelic replacement, forming DU5809 (28) . In (Fig. 2) .
The plasmid carrying Acoa::Tcr, pCOA18, does not have a replication system that functions in S. aureus. For the Tcr marker to be inherited and expressed in S. aureus after introduction of the plasmid into the gram-positive host by electroporation, recombination between the plasmid and the chromosome must occur. A single crossover will result in the plasmid becoming integrated into the chromosome with a concomitant duplication of the coa locus (Fig. 3A) . A double crossover is required for allelic replacement (Fig. 3B) . Plasmid pCOA18 was transformed into S. aureus RN4220 by electroporation, with selection for colonies that were resistant to 2 ,ug of tetracycline per ml. One colony of the 50 tested was Coa-and was presumed to have acquired the Acoa::Tcr mutation by allelic replacement. This strain was designated DU5861. The remaining transformants were Coa+ and were thought to have a complete copy of the plasmid integrated into the coa locus. The Tcr marker of this strain (DU5861) was subsequently transduced into strain Newman. All of the transductants tested were Coa-, thus demonstrating linkage between the drug resistance marker and the coagulase mutation. DU5861 was presumed to have acquired the Acoa::Tcr mutation by allelic replacement. One transductant (DU5872, Newman Acoa::Tcr) was kept for further analysis.
The remaining Tcr pCOA18 transformants of strain RN4220 expressed coagulase activity. They were presumed to have arisen by integration of plasmid pCOA18 into the coa locus. The transformants fell into two groups, those that expressed low-level tetracycline resistance (<15 ,ug/ml; 6 of 49) and those that expressed high-level tetracycline resistance (>30 ,ug/ml; 42 of 49). It was assumed that the low-level Tcr Coa+ transformants contained a single copy of pCOA18 inserted into the coa locus. One strain, DU5864, was analyzed further.
Transduction of coa::pCOA18. It has been reported that propagation of a transducing phage on a strain carrying an integrated copy of a plasmid such as pCOA18, which carries an in vitro-constructed mutation, and subsequently infecting a wild-type recipient and selecting for the drug marker associated with the mutation promotes plasmid excision and allelic replacement at a high frequency (33) . Accordingly, phage 85 was propagated on the Coa+ pCOA18 integrant DU5864 (RN4220 coa::pCOA18), and Tcr transductants were selected in Newman Coa+. In one experiment, 6 of 31 transductants were coagulase deficient and expressed lowlevel Tcr, suggesting that plasmid excision had occurred, leaving the Acoa::Tcr mutation in the coa locus (Fig. 3) samples were also probed with pCW59 (carrying the Tcr fragment used in constructing the Acoa::Tcr mutation). A single 5.4-kb fragment hybridized to the pCOA14 probe in the Newman Coa+ sample (Fig. 4, lane A) . A fragment of the same size occurred in RN4220 Coa+ (data not shown). In contrast, Newman Acoa::Tcr has fragments of 3.05 and 2.5 kb (Fig. 4, lane B) . This is explained by the presence of a KpnI site within the Tcr fragment inserted into the coa locus (Fig. 5) . Consistent with this is the observation that the Tcr probe also hybridized to fragments of the same size (Fig. 4,  lane D) . No hybridization occurred with the Tcr probe in the Coa+ sample (Fig. 4, lane C) . The samples were also cleaved with EcoRV, an enzyme that cuts within the Tcr insert as well as within the coa gene KpnI fragment (Fig. 5) . Two fragments (>15 and 3.65 kb) hybridized to the coa probe in the Newman wild-type sample (Fig. 4, lane G) , while three fragments (>15, 3.65, and 1.73 kb) hybridized to the coa probe in the putative Acoa::Tcr mutant (Fig. 4, lane H) . The >15-kb fragment is composed partly of Tcr sequences and partly of coa sequences in contrast to the >15-kb fragment from the wild type (Fig. 5) . The same results were obtained with the putative allele replacement mutant isolated directly by electroporation of RN4220 with pCOA18 DNA (data not shown).
A RN4220 pCOA18 Tcr transformant that expressed lowlevel resistance was also examined by Southern hybridization. Genomic DNA was cut with KpnI and hybridized with the coa probe (Fig. 4, lane I) (Fig. 3 and 5) .
To verify the structure of the 3' part of the mutated coa gene in Acoa::Tcr, a 640-bp HindIII-TaqI fragment from pCOA5 was purified and used as a probe for DNA sequences located at the 3' end of the coa gene. When cleaved with TaqI and HindIII, a fragment the same size as the probe hybridized in the Newman Coa+ sample (Fig. 4 , lane E) while a fragment of 450 bp hybridized in the Acoa::Tcr mutant (Fig. 4, lane F) . The intensity of this fragment was lower probably because it contains only about 160 bp of DNA that is complementary to the probe.
Expression of clumping factor. The two allelic replacement mutants of S. aureus Newman (DU5854 and DU5856) were completely devoid of coagulase activity (Table 3 ). In contrast, when titrated with human fibrinogen, both strains expressed the same level of clumping factor as the parental strain. This strongly suggests that coagulase cannot be clumping factor. This conclusion was reinforced by the expression of the cloned Newman coagulase gene when it was introduced into the Coa-8325-4 strain DU5809. Wildtype 8325-4 expressed low levels of both coagulase and clumping factor. Plasmid pNCOA5, which carries the cloned Newman coagulase gene, was transferred into DU5809. The level of coagulase expressed was increased to that expressed by strain Newman (Table 3) . However, the clumping factor titer was not raised. Thus, there was no correlation between the coagulase and clumping factor titers.
Adherence to solid-phase fibrinogen. The ability of S. aureus Newman and the Coa-mutants DU5854 and DU5856 to adhere to solid-phase fibrinogen is shown quantitatively in Fig. 6 . Coverslips which did not contain fibrinogen (albumin controls) bound <4 x 103 CFU. Adherence was promoted by fibrinogen adsorbed on PMMA. This increased linearly as a function of the amount of fibrinogen adsorbed. The doseresponse curves of strain Newman and the Coa-mutants were indistinguishable. This clearly demonstrates that coagulase cannot be responsible for the adherence of S. aureus Newman to solid-phase fibrinogen.
Analysis of fibrinogen-binding proteins. Fibrinogen-binding proteins expressed by S. aureus Newman were investigated by Western affinity blotting (4). Proteins extracted from washed cells and proteins from culture supernatants of the wild-type Coa+ strain and the Coa-mutant DU5854 (Acoa::Tcr) were compared. Both supernatants and cell extracts contained several polypeptides that reacted with fibrinogen, as was detected by using a monoclonal antifibrinogen antibody (Fig. 7, lanes C and D) . The largest and most intensely stained band was 87 kDa, the size previously reported for coagulase (4) . Several of the smaller bands may be proteolytic fragments of the 87-kDa protein, namely, the bands that were missing in the Coa-mutant sample (Fig. 7,  lanes B and E) . Similarly sized bands also reacted with anticoagulase serum (Fig. 7, lanes G and H) . The other band that reacted with fibrinogen is a 19-kDa polypeptide. This protein was not labelled when fibrinogen was omitted (Fig. 7,  lane A) , and it did not react with the anti-Newman coagulase serum (Fig. 7, lanes F to I) . Boden and Flock also identified a 19-kDa fibrinogen-binding protein (4) .
A 60-kDa protein was identified as protein A. It was labelled when fibrinogen was omitted from a control blot (Fig. 7, lane A) .
Localization of the fibrinogen-binding region of coagulase. In an effort to locate the fibrinogen-binding region on the coagulase of strain Newman, two deletions were constructed in the cloned Newman coa gene which resulted in the expression of truncated coagulase molecules. In plasmid pNCOA6, DNA encoding the C-terminal 177 amino acids was removed by subcloning in pUCKanl8. Knowledge of the DNA sequence of the closely related 8325-4 coagulase gene (28) suggested that a protein of 57 kDa would be expressed. The shuttle plasmid pNCOA6 was transferred into S. aureus 8325-4 Coa-, and coagulase activity was detected in the culture supernatants. Western blotting with anticoagulase serum revealed a major protein of 65 kDa (Fig.  8, lane A) that was absent in the control experiment with the plasmid-free host strain (data not shown). This protein failed to react with fibrinogen in the Western blotting assay (Fig.  8, lane B) . Additional polypeptides were observed in the pNCOA6 sample and in Newman coa+ (Fig. 8, lanes A and  C) . These were probably due to proteolysis.
A lacZ-coa fusion was constructed by cloning DNA 3' to the Hindlll site in coa into pUCKanl9. An in-frame fusion with lacZ was constructed, resulting in the expression of a protein comprising the N-terminal 13 residues of ,B-galactosidase and the C-terminal 177 residues of coagulase. Indeed, a polypeptide of 25 kDa was detected in the cytoplasm of E. coli carrying pNCOA8 in Western blots probed with both anticoagulase serum (Fig. 8 , lane F) and fibrinogen (Fig. 8 , lane E). In both cases, no reactions were detected in plasmid-free control samples. These data suggest that coagulase binds fibrinogen at a site that is distinct from the well-documented N-terminal prothrombin-binding region (17, 18, 27) F) , and E. coli TB1 (plasmid free) (lane G).
However, the biological significance of this reaction between coagulase and fibrinogen is not clear. The Coamutants were completely devoid of plasma clotting activity but clumped normally in fibrinogen solution and still adhered avidly to solid-phase fibrinogen. Furthermore, when the cloned Newman coa gene was transferred into 8325-4, a strain which expressed a low coagulase titer and which clumped poorly in fibrinogen, the clumping titer did not increase concomittantly with the coagulase titer. Clearly, coagulase cannot be clumping factor. Presumably, the fibrinogen-binding region of cell-bound coagulase is not surface exposed and cannot react with fibrinogen.
It could be argued that the apparent reaction between coagulase and fibrinogen demonstrated by affinity blotting is an artifact of contamination of fibrinogen preparations with prothrombin and that the reaction of coagulase with fibrinogen is mediated by a coagulase-prothrombin complex. Alternatively, coagulase could react with fibrinogen independently of prothrombin. We favor the latter hypothesis because the region of coagulase required for fibrinogen binding appears to be located in the C terminus of the molecule whereas prothombin binds to the N terminus. We have expressed two fusion proteins derived from the Newman coagulase. One protein of 25 kDa which comprises the first 13 amino acids of ,B-galactosidase at the N terminus fused to the carboxy-terminal 177 residues of coagulase. This protein was expressed in E. coli. It did not clot plasma (because it lacks the prothrombin-binding region) but reacted with both the anticoagulase serum and fibrinogen. Conversely, a deletion mutant lacking DNA coding for the C-terminal 177 residues expressed an immunoreactive truncated protein that failed to react with fibrinogen but retained plasma clotting activity.
In this report, we have also demonstrated that it is feasible to isolate allelic replacement mutants in a single step by electroporating a nonreplicating suicide plasmid into S. aureus RN4220. The transformation frequency obtained by electroporation was sufficiently high for double recombinants to be selected. However, a more frequent outcome of introducing a suicide plasmid was integration at the site of chromosomal homology by a single crossover event (Campbell insertion). Another approach that does not depend on high-frequency plasmid transformation is to introduce the mutation into S. aureus on a temperature-sensitive vector and then to select for integration into the chromosome by elevating the growth temperature (12). We have confirmed an earlier finding made with a temperature-sensitive plasmid integrated in the tst locus (34) that it is possible to resolve the cointegrate by transduction to a wild-type recipient (Fig. 3) . Resolution occurred by recombination in the duplicated region on the opposite side of the mutation to that which led to plasmid integration. We also noted that amplification of the integrated pCOA18 occurred frequently, generating derivatives that expressed a higher level of tetracycline resistance. Southern blotting experiments have shown that this occurs by tandem duplication and multimerization (22a) .
